Transferrin Saturation and Iron Replacement Guidelines

Diagnosis and Clinical Significance

A transferrin saturation (TSAT) < 20 % demonstrates high sensitivity for detecting absolute or functional iron deficiency. 1
TSAT values around 7 % indicate severe iron deficiency that warrants urgent iron repletion. 1
TSAT below the normal range signals insufficient iron for erythropoiesis even when ferritin is normal. 2
The lower the TSAT, the greater the probability of clinically important iron deficiency. 2

Ferrous sulfate 325 mg (≈65 mg elemental iron) taken once daily or every other day is an appropriate initial regimen.
Alternate‑day dosing provides comparable efficacy to daily dosing while producing fewer gastrointestinal adverse events. 3
Multiple daily doses raise hepcidin, which blocks subsequent iron absorption; therefore, twice‑ or three‑times‑daily regimens are counter‑productive. 3
Alternate‑day dosing permits hepcidin levels to return to baseline between doses, potentially enhancing overall iron uptake. 3
Concomitant use of proton‑pump inhibitors, H₂‑blockers, calcium supplements, or antacids impairs oral iron absorption and should be avoided. 3

Chronic kidney disease (eGFR < 60 mL/min/1.73 m²) is a strong indication for IV iron rather than oral therapy. 4
Chronic heart failure patients benefit from IV iron, especially formulations with proven cardiovascular mortality reduction. 4
Situations requiring rapid iron repletion (e.g., severe anemia, pre‑operative optimization) favor IV iron. 1

Ferric derisomaltose is the only FDA‑approved product for total‑dose infusion up to 1500 mg and has demonstrated cardiovascular mortality benefit in heart‑failure cohorts. 1
Alternative IV iron agents include ferric carboxymaltose, iron sucrose, and low‑molecular‑weight iron dextran. [1][5]
High‑molecular‑weight iron dextran should be avoided because of a higher risk of anaphylaxis. [6][5]

Re‑evaluate complete blood count, ferritin, and TSAT 4–8 weeks after initiating oral iron therapy. 1
Effective treatment typically raises hemoglobin by 1–2 g/dL within the 4–8‑week window. 1
After IV iron administration, defer repeat iron studies for at least 4 weeks to avoid assay interference from circulating iron. 1

Screen for occult gastrointestinal bleeding (upper and lower endoscopy) in males and post‑menopausal females when iron deficiency is identified. 4
Assess renal function (serum creatinine, eGFR) to detect chronic kidney disease that may influence iron‑replacement strategy. [6][4]

Do not prescribe three‑times‑daily oral iron; it increases side‑effects without improving efficacy.
Do not rely solely on oral iron in dialysis‑dependent CKD patients; IV iron is required due to ongoing losses and poor gut absorption. [2][4]
Do not use TSAT alone to gauge iron stores; always combine with ferritin measurement because TSAT fluctuates day‑to‑day.
Do not assume oral‑iron failure without first confirming adherence, proper timing relative to meals, and absence of interacting medications. 3
Do not continue oral iron indefinitely without reassessment; a 4–8‑week review determines whether escalation to IV iron is needed. 1

The transferrin saturation (%) is calculated as (serum iron ÷ total iron‑binding capacity) × 100. This formula is endorsed by the MMWR Recommendations. 7
To convert transferrin concentration (mg/dL) to total iron‑binding capacity (µg/dL), multiply the transferrin value by 1.25; this conversion is recommended by the MMWR Recommendations. 8

In healthy adults, transferrin saturation normally lies between 20 % and 50 %. 9
Values below 16 %–20 % are indicative of iron deficiency. 7
Values above 45 %–50 % in females or above 50 %–55 % in males suggest possible iron overload and warrant evaluation for hereditary hemochromatosis. 10

Males: transferrin saturation > 50 % and serum ferritin > 300 µg/L should trigger HFE‑gene testing. (Guideline: Journal of Hepatology) 10
Females: transferrin saturation > 45 % and serum ferritin > 200 µg/L should trigger HFE‑gene testing. (Guideline: Journal of Hepatology) 10
Transferrin saturation > 55 % has been linked to increased all‑cause mortality. (Evidence from Annals of Internal Medicine) 11

Transferrin saturation shows significant diurnal variation—higher in the morning and lower in the evening. (MMWR Recommendations) 7
Levels rise after meals; fasting samples are preferred for accurate assessment. (MMWR Recommendations) 7
Inflammation, infection, or chronic disease can lower transferrin saturation independent of iron status. (MMWR Recommendations) 7
Day‑to‑day variability of transferrin saturation is greater than that of hemoglobin or ferritin. (MMWR Recommendations) 7

Measure serum ferritin to complete the iron status profile. (Journal of Hepatology; Clinical Gastroenterology and Hepatology) 10
If ferritin is also elevated (>200 µg/L in females or >300 µg/L in males), proceed with HFE genetic testing for hereditary hemochromatosis. (Journal of Hepatology) 10
Repeat a fasting morning sample to confirm the elevation, accounting for diurnal variation. (MMWR Recommendations) 7
Evaluate for secondary causes of increased iron such as liver disease, excessive alcohol intake, or chronic inflammatory conditions. (Journal of Hepatology) 10